These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 19271025
1. The effects of trimetazidine on lipid peroxidation in patients with end-stage renal disease. Aygen B, Celiker H, Dogukan A, Ilhan N. Methods Find Exp Clin Pharmacol; 2008 Dec; 30(10):757-60. PubMed ID: 19271025 [Abstract] [Full Text] [Related]
2. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution. Günal AI, Celiker H, Ustundag B, Akpolat N, Dogukan A, Akcicek F. J Nephrol; 2003 Dec; 16(2):225-30. PubMed ID: 12768069 [Abstract] [Full Text] [Related]
3. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients. De Vecchi AF, Bamonti F, Novembrino C, Ippolito S, Guerra L, Lonati S, Salini S, Aman CS, Scurati-Manzoni E, Cighetti G. Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746 [Abstract] [Full Text] [Related]
4. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Lucchi L, Bergamini S, Iannone A, Perrone S, Stipo L, Olmeda F, Caruso F, Tomasi A, Albertazzi A. Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086 [Abstract] [Full Text] [Related]
5. Effect of vitamin E therapy on oxidative stress and erythrocyte osmotic fragility in patients on peritoneal dialysis and hemodialysis. Uzum A, Toprak O, Gumustas MK, Ciftci S, Sen S. J Nephrol; 2006 Jan; 19(6):739-45. PubMed ID: 17173246 [Abstract] [Full Text] [Related]
6. Lipid peroxidation and glutathione levels after cortical injection of ferric chloride in rats: effect of trimetazidine and deferoxamine. Suzer T, Coskun E, Demir S, Tahta K. Res Exp Med (Berl); 2000 Feb; 199(4):223-9. PubMed ID: 10743680 [Abstract] [Full Text] [Related]
7. Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis. Ahmadpoor P, Eftekhar E, Nourooz-Zadeh J, Servat H, Makhdoomi K, Ghafari A. Iran J Kidney Dis; 2009 Jan; 3(1):22-7. PubMed ID: 19377255 [Abstract] [Full Text] [Related]
8. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment. Göçmen AY, Sahin E, Koçak H, Tuncer M, Gümüşlü S. Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672 [Abstract] [Full Text] [Related]
9. Effects of trimetazidine on lipid peroxidation, antioxidant enzyme activities and plasma brain natriuretic peptide levels in patients with chronic cor pulmonale. Bayram E, Atalay C, Kocatürk H, Yücel O. J Int Med Res; 2005 Jul; 33(6):612-9. PubMed ID: 16372578 [Abstract] [Full Text] [Related]
10. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease. Kalogerakis G, Baker AM, Christov S, Rowley KG, Dwyer K, Winterbourn C, Best JD, Jenkins AJ. Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192 [Abstract] [Full Text] [Related]
11. Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect. Belardinelli R, Solenghi M, Volpe L, Purcaro A. Eur Heart J; 2007 May; 28(9):1102-8. PubMed ID: 17456483 [Abstract] [Full Text] [Related]
12. Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease. Pawlak K, Pawlak D, Mysliwiec M. Clin Biochem; 2005 Aug; 38(8):700-5. PubMed ID: 15963971 [Abstract] [Full Text] [Related]
13. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Torun AN, Kulaksizoglu S, Kulaksizoglu M, Pamuk BO, Isbilen E, Tutuncu NB. Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709 [Abstract] [Full Text] [Related]
14. Compositional and oxidative analysis in the saliva and serum of predialysis chronic kidney disease patients and end-stage renal failure patients on peritoneal dialysis. Bibi G, Green Y, Nagler RM. Ther Apher Dial; 2008 Apr; 12(2):164-70. PubMed ID: 18387167 [Abstract] [Full Text] [Related]
15. Effect of hemodialysis on total antioxidant status of chronic renal failure patients in government hospitals in Lagos Nigeria. Ajala MO, Ogunro PS, Odun A. Niger J Clin Pract; 2011 Apr; 14(2):154-8. PubMed ID: 21860130 [Abstract] [Full Text] [Related]
16. [Assessment of malonyldialdehyde concentration as a product of lipid peroxidation and lipid metabolism in patients on chronic dialysis]. Miler M, Zamojska S, Fijałkowski P, Lobos M, Paradowski MT. Pol Merkur Lekarski; 2006 Jun; 20(120):664-7. PubMed ID: 17007263 [Abstract] [Full Text] [Related]
17. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis. Lucchi L, Iannone A, Bergamini S, Stipo L, Perrone S, Uggeri S, Gatti V, Ferrari F, Tomasi A, Albertazzi A. Artif Organs; 2005 Oct; 29(10):832-7. PubMed ID: 16185346 [Abstract] [Full Text] [Related]
18. Oxidative stress in chronic renal failure as a cardiovascular risk factor. Siems W, Quast S, Carluccio F, Wiswedel I, Hirsch D, Augustin W, Hampi H, Riehle M, Sommerburg O. Clin Nephrol; 2002 Jul; 58 Suppl 1():S12-9. PubMed ID: 12227720 [Abstract] [Full Text] [Related]
19. Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Karamouzis I, Sarafidis PA, Karamouzis M, Iliadis S, Haidich AB, Sioulis A, Triantos A, Vavatsi-Christaki N, Grekas DM. Am J Nephrol; 2008 Jul; 28(3):397-404. PubMed ID: 18063858 [Abstract] [Full Text] [Related]